Cancer Treatment News and Research

RSS

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Lung cancer is not the most common form of cancer, but it is by far the deadliest.

23 Feb 2024

Understanding how stress accelerates cancer spread

Stress is inevitable. But too much of it can be terrible for our health. Chronic stress can increase our risk for heart disease and strokes.

22 Feb 2024

Natural killer cells lead the charge in cancer treatment innovation

Review synthesizes research on NK cells' role in cancer immunity and their potential in therapeutics through bioengineering, immune checkpoint inhibitors, and cell engagers, highlighting ongoing preclinical and clinical trials.

22 Feb 2024

Can dietary patterns impact stomach cancer risk?

Eating patterns and indices related to gastric cancer and explored their association with stomach cancer risk.

22 Feb 2024

Red light exposure mitigates blood glucose spikes after meals

Shining a specific frequency of red light on a person's back for 15 minutes can reduce blood sugar levels, according to a new study from City, University of London and UCL.

22 Feb 2024

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group awarded $20 million from the University of Tennessee-Oak Ridge Innovation Institute in partnership with Oak Ridge National Laboratory and the University of Tennessee, Knoxville, to develop new radiopharmaceutical therapies to treat cancer.

21 Feb 2024

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

The University of Texas MD Anderson Cancer Center today was awarded 16 grants totaling over $25.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer screening, early detection and prevention programs, faculty recruitment, and groundbreaking cancer research across all areas of the institution.

21 Feb 2024

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Announcing a new publication for Acta Materia Medica journal. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment but pose a challenge of immune-related adverse events (irAEs), particularly endocrine toxicity, that can severely compromise patient well-being.

21 Feb 2024

Red light therapy lowers blood sugar and mitigates glucose spikes

The researchers found that 670 nanometers (nm) of red light stimulated energy production within mitochondria, the tiny powerhouses within cells, leading to increased consumption of glucose. In particular, it led to a 27.7% reduction in blood glucose levels following glucose intake, and it reduced maximum glucose spiking by 7.5%.

20 Feb 2024

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

In a step forward for breast cancer treatment, researchers at Tohoku University have developed a novel monoclonal antibody which specifically targets a certain type of breast cancer cell.

19 Feb 2024

Lockdown delays in melanoma diagnosis cost Europe £6bn and thousands of lives

Delays in diagnosing melanoma due to Covid-19 lockdown may have contributed to over 100,000 years of life lost across Europe and over £6bn in costs, mainly indirectly due to loss of productivity, finds a new study led by UCL and University Hospital of Basel researchers.

16 Feb 2024

New Blood Cancer Healing Center poised to redefine care standards

The Blood Cancer Healing Center, located at 3229 Burnet Avenue in Uptown Cincinnati, is poised to redefine care standards by offering comprehensive patient support and innovative treatments under one roof.

15 Feb 2024

Novel three-drug combo shows promise in advanced HER2-negative breast cancer treatment

A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.

14 Feb 2024

New AI-powered protein mapping tool optimizes cancer therapy

Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumour, enabling clinicians to decide how to target treatment in a more precise way.

13 Feb 2024

Novel assay enhances pediatric cancer treatment by identifying clinically relevant gene fusions

Identification of specific gene fusions is critical for the successful targeted treatment of pediatric cancer patients.

13 Feb 2024

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

A diet that limits meat and dairy but is rich in fruits, vegetables, grains, and nuts is linked to less erectile dysfunction, urinary incontinence, and other common side effects seen in prostate cancer patients, a new study shows.

13 Feb 2024

New method traces primed resistance in cancer via sister cells

In many cancers, such as ovarian cancer, each round of chemotherapy kills the majority of cancer cells, while a small population of them survives through treatment.

12 Feb 2024

AI tool maps protein function in tumors, paving way for personalized cancer treatment

Scientists have developed a new AI tool that maps the function of proteins in a cancerous tumor, enabling clinicians to decide how to target treatment in a more precise way.

9 Feb 2024

New immunotherapy borrows cancer's tricks to unleash powerful T cells

Immunotherapies using engineered T cells have ushered in a new era in cancer treatment, but they have their limits. They may cause side effects or stop working, and they do not work at all against 90% of cancers.

8 Feb 2024

NCCN publishes first-ever treatment recommendations pertaining to neuroblastoma

The National Comprehensive Cancer Network (NCCN) - an alliance of leading cancer centers - today published its first ever set of treatment recommendations pertaining to neuroblastoma.

8 Feb 2024

Cancer Treatment News and Research

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Understanding how stress accelerates cancer spread

Natural killer cells lead the charge in cancer treatment innovation

Can dietary patterns impact stomach cancer risk?

Red light exposure mitigates blood glucose spikes after meals

Collaborative project gets $20 million to develop new radiopharmaceutical cancer therapies

CPRIT awards MD Anderson 16 grants to support cancer research and prevention

Comprehensive analysis of immune checkpoint inhibitors reveals endocrine toxicity patterns

Red light therapy lowers blood sugar and mitigates glucose spikes

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Lockdown delays in melanoma diagnosis cost Europe £6bn and thousands of lives

New Blood Cancer Healing Center poised to redefine care standards

Novel three-drug combo shows promise in advanced HER2-negative breast cancer treatment

New AI-powered protein mapping tool optimizes cancer therapy

Novel assay enhances pediatric cancer treatment by identifying clinically relevant gene fusions

Plant-based diet linked to less erectile dysfunction, urinary incontinence in prostate cancer patients

New method traces primed resistance in cancer via sister cells

AI tool maps protein function in tumors, paving way for personalized cancer treatment

New immunotherapy borrows cancer's tricks to unleash powerful T cells

NCCN publishes first-ever treatment recommendations pertaining to neuroblastoma

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News